Dried blood spot test could revolutionize virus screening in drug users
NCT ID NCT05390424
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to see if a dried blood spot test can effectively screen drug users for hepatitis B, hepatitis C, and AIDS. Researchers will enroll 500 former or active drug users. The goal is to find a simpler way to detect these infections in a hard-to-reach population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AIDS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aides Region Normandie
RECRUITINGRouen, 76000, France
-
Caarud Sud Manche
RECRUITINGAvranches, 50300, France
-
Chu Rouen
RECRUITINGRouen, 76031, France
-
Csapa Act
RECRUITINGElbeuf, 76500, France
-
Csapa Barentin
RECRUITINGBarentin, 76360, France
-
Csapa Caux Et Bray
RECRUITINGYvetot, 76190, France
-
Csapa Gisors
RECRUITINGGisors, 27140, France
-
Csapa Nautilia
RECRUITINGLe Havre, 76600, France
-
Csapa Pont-Audemer
RECRUITINGPont-Audemer, 27504, France
-
Csapa-Caarud La Boussole
RECRUITINGRouen, 76000, France
-
Oeuvre Normande Des Meres
RECRUITINGDieppe, 76200, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A Finger-Prick could change the fight against hepatitis c
- A simple finger prick could transform hepatitis c care
- Can coaching clinics curb HIV? a new strategy puts it to the test
- Can hepatitis c be cured in just 4 weeks? a new trial puts it to the test
- Can a simple roadside test catch liver disease before it turns deadly?
- Pharmacy-Based hepatitis c testing could cure more people on opioid therapy